Tribunal Overturns Disallowances, Pharmaceutical Company Expenses Deemed Legitimate Business Expenditures

The Tribunal allowed the appeal, overturning the disallowances made by the AO and upheld by the CIT(A). It held that expenses incurred by the pharmaceutical company were legitimate business expenditures under Section 37(1) of the Income Tax Act. The Tribunal emphasized that the CBDT Circular and MCI regulations do not apply retrospectively to pharmaceutical companies, thereby justifying the expenses claimed by the assessee.

---

---

Issues Involved:
1. Disallowance under Section 37(1) of the Income Tax Act for expenses classified as freebies.
2. Disallowance of expenditure claimed as 'Non-freebies' under Section 37(1) of the Income Tax Act under various heads.

Detailed Analysis:

1. Disallowance under Section 37(1) of the Income Tax Act for expenses classified as freebies:
The primary issue revolves around the disallowance of Rs. 3,55,20,081/- under Section 37(1) of the Income Tax Act, which the AO classified as freebies given to doctors. The AO's stance was based on the CBDT Circular No. 5/2012 dated 01.08.2012, which stated that expenses incurred on freebies provided to medical practitioners violate the Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulations, 2002, and are thus inadmissible under Section 37(1) as they are considered expenses prohibited by law.

The Tribunal, however, noted that the Medical Council of India (MCI) regulations apply to medical practitioners and not to pharmaceutical companies. The Tribunal cited several decisions, including the case of Aristo Pharmaceuticals P.Ltd. Vs. ACIT, where it was held that the MCI regulations do not impinge on the conduct of pharmaceutical companies. The Tribunal emphasized that the CBDT Circular cannot retrospectively impose a burden on pharmaceutical companies, and the disallowance based on this circular was not justified.

2. Disallowance of expenditure claimed as 'Non-freebies' under Section 37(1) of the Income Tax Act under various heads:
The assessee also contested the disallowance of Rs. 1,00,67,842/- under various heads such as business convention expenses, CME expenses, MCM expenses, promotional material, and sales promotion expenses. The AO had equated these expenditures to freebies and disallowed them. The CIT(A) concurred with the AO, emphasizing that such expenses, even if not classified as freebies, were against public policy and thus not allowable.

The Tribunal, however, analyzed each category of expenditure and concluded that these expenses were incurred for legitimate business purposes. The Tribunal referenced the decision in the case of Aristo Pharmaceuticals P.Ltd., where it was established that the circular issued by the CBDT cannot be applied retrospectively. The Tribunal observed that the expenses were essential for the business operations of a pharmaceutical company and did not fall under the category of expenses prohibited by law.

Conclusion:
The Tribunal allowed the appeal of the assessee, deleting the disallowances made by the AO and confirmed by the CIT(A). The Tribunal's decision was based on the interpretation that the MCI regulations and the CBDT Circular No. 5/2012 do not apply retrospectively to pharmaceutical companies, and the expenses incurred were legitimate business expenditures under Section 37(1) of the Income Tax Act.

Order:
The appeal of the assessee is allowed, and the disallowances are deleted. The order was pronounced in the Court on 15th October 2019 at Ahmedabad.

---